GJANA, ORIOLA

GJANA, ORIOLA  

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale  

Mostra records
Risultati 1 - 9 di 9 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Therapeutic potential of HDAC8 Inhibition and SIRT1 activation in Duchenne muscular dystrophy 2025 S. CarboneA. BrixL. LociuroO. GjanaM. SchiavoneA. MarozziC. De PalmaA. PistocchiA. Pezzotta + Conference Object -
Therapeutic potential of HDAC8 Inhibition and SIRT1 activation in Duchenne muscular dystrophy 2025 S. CarboneA. BrixL. LociuroO. GjanaM. SchiavoneA. MarozziC. De PalmaA. PistocchiA. Pezzotta + Conference Object -
Combination therapy targeting HDAC8 and SIRT1 improves muscle integrity in a dmd zebrafish model 2025 S. CarboneA. BrixL. LociuroO. GjanaM. SchiavoneA. MarozziC. De PalmaA. PezzottaA. Pistocchi + Conference Object -
The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recovery 2025 Giovarelli, MatteoCasati, Silvia RosannaLociuro, LauraGjana, OriolaMollica, LucaMbissam, Harcel DjayaArcari, AlessandroClerici, GiudittaCattaneo, Maria GraziaBanfi, CristinaBrunetti, DarioMocciaro, EmanueleClementi, EmilioPerrotta, CristianaDe Palma, Clara + Article (author) -
SRT2104, a new SIRT1 activator, is an effective metabolic enhancer that promotes muscle recovery in DMD 2024 L. LociuroO. GjanaS. R. CasatiS. ZecchiniM. GiovarelliD. BrunettiG. ClericiM. G. CattaneoC. BanfiL. MollicaC. De Palma Conference Object -
Enhancing micro-dystrophin gene therapy: the role of SRT2104, a new Sirtuin1-activating compound, for the treatment of Duchenne Muscular Dystrophy 2024 L. LociuroS. R. CasatiO. GjanaS. ZecchiniM. GiovarelliC. PerrottaC. De Palma Conference Object -
Enhancing micro-dystrophin gene therapy: the role of SRT2104, a new Sirtuin1-activating compound, for the treatment of Duchenne Muscular Dystrophy 2024 L. LociuroS. R. CasatiO. GjanaS. ZecchiniM. GiovarelliC. PerrottaC. De Palma Conference Object -
Enhancing micro-dystrophin gene therapy: the role of SRT2104, a new Sirtuin1-activating compound, for the treatment of Duchenne Muscular Dystrophy 2024 L. LociuroS. R. CasatiO. GjanaS. ZecchiniM. GiovarelliC. PerrottaC. De Palma Conference Object -
Targeting mitochondrial dynamics to tackle Duchenne Muscular Dystrophy progression 2024 S. R. CasatiO. GjanaS. ZecchiniM. GiovarelliC. PerrottaM. CacciaC. De Palma + Conference Object -